← Back to Search

Cognitive Intervention

Telemedicine Intervention for Chronic Pain in Parkinson's Disease

N/A
Recruiting
Led By David William Sparrow, DSc
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Physician diagnosis of idiopathic PD
At least 2 of the 3 cardinal signs of PD (resting tremor, rigidity, bradykinesia)
Must not have
History of ventricular dysrhythmia requiring current therapy
Angina pectoris
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests home-based physical and mental exercises to reduce pain in Veterans with Parkinson's disease. The exercises aim to make the body stronger and the mind more focused, helping to lessen the feeling of pain.

Who is the study for?
This trial is for individuals with Parkinson's Disease who experience chronic pain. Participants must have a physician's diagnosis of idiopathic PD, show at least two key symptoms (resting tremor, rigidity, or slow movement), and respond to medication that increases dopamine. It excludes those with recent heart issues like angina or myocardial infarction within the last six months.
What is being tested?
The study tests home-based physical and cognitive exercises along with health education as interventions to reduce pain in Parkinson's patients using telemedicine. This could help veterans maintain these practices indefinitely through remote access technology.
What are the potential side effects?
While specific side effects are not detailed here, typical risks may include muscle soreness from physical exercise and mental fatigue from cognitive tasks; however, these activities are generally considered safe.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Parkinson's disease by a doctor.
Select...
I show at least 2 key symptoms of Parkinson's disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently being treated for irregular heartbeats.
Select...
I have chest pain due to heart problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Physical exercise interventionExperimental Treatment1 Intervention
Participants will receive the physical exercise intervention for 3 months.
Group II: Combined physical and cognitive exercise interventionExperimental Treatment2 Interventions
Participants will receive both the physical exercise intervention and the cognitive exercise intervention for 3 months.
Group III: Cognitive exercise interventionExperimental Treatment1 Intervention
Participants will receive the cognitive exercise intervention for 3 months.
Group IV: Control groupActive Control1 Intervention
Participants will receive health education for 3 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical exercise intervention
2021
N/A
~600

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Parkinson's Disease (PD) include pharmacologic therapies like levodopa, dopamine agonists, and MAO-B inhibitors, which work by replenishing or mimicking dopamine to alleviate motor symptoms. Non-pharmacologic treatments, such as home-based physical and cognitive exercise interventions, aim to improve muscle strength, flexibility, and cognitive function. These interventions are particularly important for PD patients as they can enhance pain perception and coping strategies, thereby managing chronic pain and improving overall quality of life.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,427,122 Total Patients Enrolled
David William Sparrow, DScPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
8 Previous Clinical Trials
1,245 Total Patients Enrolled

Media Library

Cognitive exercise intervention (Cognitive Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05410392 — N/A
Parkinson's Disease Clinical Trial 2023: Cognitive exercise intervention Highlights & Side Effects. Trial Name: NCT05410392 — N/A
Cognitive exercise intervention (Cognitive Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05410392 — N/A
~67 spots leftby Feb 2026